HIGHLIGHTS
- who: Burden AM from the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto ON, Canada have published the research: Examining Exposure Misclassification of Oral Bisphosphonate Therapy and the Associated Fracture Risk: A Cohort Study, in the Journal: (JOURNAL)
- what: The authors examined the impact of exposure misclassification in pharmacy claims data on estimates of drug effectiveness using osteoporosis pharmacotherapy and hip fractures as a case example.
SUMMARY
Using pharmacy claims data the authors previously identified exposure misclassification in pharmacy claims data that underestimated oral bisphosphonate compliance, particularly in long-term . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.